share_log

爱尔眼科(300015.SZ)：视光业务是从预防、控制到治疗的完整体系，除低浓度阿托品外，还有OK镜、离焦软镜、离焦框架眼镜等多种近视防控产品

Aier Ophthalmology (300015.SZ): The optometry business is a complete system from prevention, control to treatment. In addition to low-concentration atropine, there are also various myopia prevention and control products such as OK lenses, defocused soft l

Gelonghui Finance ·  Mar 14 04:37

On March 14, Ge Longhui Ophthalmology (300015.SZ) said on the investor interactive platform that the company is closely following the progress and development of ophthalmology diagnosis and treatment technology at home and abroad. In terms of the prevention and control of myopia among young people, the company has obtained the “Medical Institution Formulation License”, its 0.05% atropine eye drops have obtained relevant approval, and the product has entered clinical practice. At this stage, the incidence of myopia is high, and there is a clear trend of getting younger and more advanced. The task of preventing and controlling myopia among young people is very heavy, and there is a growing demand for the use of prevention and control products. The company's optometry business is a complete system from prevention, control to treatment. In addition to low-concentration atropine, there are also various myopia prevention and control products such as OK lenses, defocused soft lenses, and defocused frame glasses.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment